Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP869337.RAJUgj8xGwSC9KFxfVCGcK1g3a6t5gHjEcVCrEQG2Vdn8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP869337.RAJUgj8xGwSC9KFxfVCGcK1g3a6t5gHjEcVCrEQG2Vdn8130_assertion type Assertion NP869337.RAJUgj8xGwSC9KFxfVCGcK1g3a6t5gHjEcVCrEQG2Vdn8130_head.
- NP869337.RAJUgj8xGwSC9KFxfVCGcK1g3a6t5gHjEcVCrEQG2Vdn8130_assertion description "[In corresponding noncancerous tissues, hypermethylation in RAR-beta and FHIT was frequently detected in 38 and 30%, respectively, whereas no VHL hypermethylation and only 4% of RASSF1A hypermethylation were detected.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869337.RAJUgj8xGwSC9KFxfVCGcK1g3a6t5gHjEcVCrEQG2Vdn8130_provenance.
- NP869337.RAJUgj8xGwSC9KFxfVCGcK1g3a6t5gHjEcVCrEQG2Vdn8130_assertion evidence source_evidence_literature NP869337.RAJUgj8xGwSC9KFxfVCGcK1g3a6t5gHjEcVCrEQG2Vdn8130_provenance.
- NP869337.RAJUgj8xGwSC9KFxfVCGcK1g3a6t5gHjEcVCrEQG2Vdn8130_assertion SIO_000772 12839965 NP869337.RAJUgj8xGwSC9KFxfVCGcK1g3a6t5gHjEcVCrEQG2Vdn8130_provenance.
- NP869337.RAJUgj8xGwSC9KFxfVCGcK1g3a6t5gHjEcVCrEQG2Vdn8130_assertion wasDerivedFrom befree-20140225 NP869337.RAJUgj8xGwSC9KFxfVCGcK1g3a6t5gHjEcVCrEQG2Vdn8130_provenance.
- NP869337.RAJUgj8xGwSC9KFxfVCGcK1g3a6t5gHjEcVCrEQG2Vdn8130_assertion wasGeneratedBy ECO_0000203 NP869337.RAJUgj8xGwSC9KFxfVCGcK1g3a6t5gHjEcVCrEQG2Vdn8130_provenance.